Musculoskeletal
-
Epic journey to support vital rheumatoid arthritis research
Posted on:
The burble of high-powered motorcycles was heard across the Kolling Institute forecourt as part of a 2000 kilometre ride from Melbourne to Armidale to raise awareness and funds for life-changing research. The ride is an initiative of Robert Hunt from the Ulysses Club which has been supporting rheumatoid arthritis research for nearly three decades. The
-
New trial to determine if diet and exercise alone can prevent knee osteoarthritis
Posted on:
In one of the first global clinical trials of its kind, researchers have launched a study to investigate if a diet and exercise program aimed at weight loss can prevent the development of crippling knee osteoarthritis. The trial will be led by researchers from the University of Sydney and the Kolling Institute in collaboration with
-
Clinical Trials Champion
Posted on:
As a clinical trials program lead at the Kolling Institute, Dr Karen Bracken has long been driven to help researchers conduct trials in the best way possible. “Researchers are passionate about their disease area and their patients, and they have so many unanswered questions,” she says. Karen comes from a family of clinicians, and while
Category:
-
Partnership to drive innovation in genomic science
Posted on:
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports
-
Kolling Research Symposium 2024
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop
-
Kolling NEWS
Posted on:
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There’s a focus too on the first steps towards gene therapy for Meniere’s disease, the latest research into treatments for
-
New collaboration to drive world leading research into osteoarthritis treatment
Posted on:
An innovative partnership with industry will see our researchers at the Kolling Institute develop evidence-based strategies to improve osteoarthritis management in Australia and globally. Consumer healthcare company Haleon is sponsoring a five-year fellowship to investigate the role of supplements in managing osteoarthritis and digital health technologies to improve mobility. Osteoarthritis is a leading cause of
-
Innovation at the Kolling’s core
Posted on:
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who
-
Research driving the development of new implants and improving outcomes
Posted on:
Our researchers at the Kolling Institute have joined with international collaborators to develop a revolutionary implant for hip replacements. The ceramic implant, designed for hip resurfacing procedures, doesn’t require the long stem used in common hip replacements. This means surgeons are not removing the bone which they would generally remove for a hip replacement. Professor
Category:
-
Research to improve postmenopausal women’s bone and muscle health
Posted on:
Kolling Institute researchers Dr. Shejil Kumar and Professor Rory Clifton-Bligh have embarked on a pioneering study to enhance bone health in postmenopausal women. The study, titled “Combining Osteoanabolic Pharmacotherapy with Osteogenic Exercise in Postmenopausal Women with Osteoporosis and Osteopenia “The ROLEX-DUO Study,” is set to recruit 100 women aged 50 and above. The primary focus
Copyright © 2026 Kolling Institute
All rights reserved